Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Interferons
>>
Phase 3
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
4
8
12
16
20
24
28
32
36
40
Actimmune
(interferon gamma-1 b) / Clinigen, Amgen
Saphnelo
(anifrolumab) / AstraZeneca
vidofludimus
(IMU-838) / Immunic
Multiferon
(interferon alpha) / SOBI
Traumakine
(IFN beta-1a) / Faron Pharma, Maruishi Pharma
dazukibart
(PF-06823859) / Pfizer
interferon beta inhalation
(SNG001) / Synairgen
tadekinig alfa
(IL-18BP) / AB2 Bio
Yallaferon
(recombinant human interferon α-2b gel) / Lee's Pharm
Algeron
(cepeginterferon alfa-2b) / Biocad
Multikine
(leukocyte interleukin injection) / CEL-SCI, Orient Europharma
Novaferon inhalation
(recombinant anti-tumor and anti-virus protein inhalation) / Genova
PEG Interferon
/ Beijing Kawin
BCD-054
(sampeginterferon beta-1a) / Biocad
Teberif
(interferon beta-1a biosimilar) / Biocad
Y-PEG IFN- α 2a
/ Xiamen Amoytop Biotech, BioGeneric Pharma
peginterferon alfa 2b 48kDA
(BIP48) / Oswaldo Cruz Foundation
BaroFeron
(IFN-β-1b) / Nuron Biotech, Pressure BioSciences, Inc.
